The status of antimicrobial resistance of Helicobacter pylori in eastern Europe.
about
H pylori antibiotic resistance: prevalence, importance, and advances in testingAntimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States.Antimicrobial susceptibility of Helicobacter pylori isolates from Lower Silesia, PolandGatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan.Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycinOrally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infectionTherapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection.Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in TurkeyEffective regimens for the treatment of Helicobacter pylori infection.Treatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics.Review article: the global emergence of Helicobacter pylori antibiotic resistance.Oral immunization with recombinant Lactobacillus acidophilus expressing the adhesin Hp0410 of Helicobacter pylori induces mucosal and systemic immune responses.Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.Detection of clarithromycin-resistant Helicobacter pylori by stool PCR in children: a comprehensive review of literature.Current options for the treatment of Helicobacter pylori.Eradication of Helicobacter pylori infection: which regimen first?Helicobacter pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy.Increasing metronidazole and rifampicin resistance of Helicobacter pylori isolates obtained from children and adolescents between 2002 and 2015 in southwest Germany.Amoxicillin resistance in Helicobacter pylori: studies from Tokyo, Japan from 1985 to 2003.Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study.Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes.Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study.Antibiotic resistance of Helicobacter pylori in Israeli children.Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.Antibiotic resistance of Helicobacter pylori in pediatric patients -- 10 years' experience.Evolution of Helicobacter pylori susceptibility to antibiotics during a 10-year period in Lithuania.Efficacy of two levofloxacin-containing second-line therapies for Helicobacter pylori: a pilot study.Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit.
P2860
Q24685864-3999A548-6ECB-42F7-87C9-D5C839827F17Q30427337-AACF62D3-082D-4E3C-AEE7-1E5A4855B414Q33935291-9D36600E-32D7-47A5-A4B2-CAC9B3FFECA8Q34510388-19B014A9-78ED-45DD-B16E-3B8259759D76Q34604699-CF79C435-96FB-4171-AEE4-C1596DC37CC0Q34941937-55905E56-F365-46B1-B4DE-2565CB6AD4E6Q35914868-D75A1295-9C6D-41DA-B165-C0A6BA660D8AQ36474120-AA831171-91DE-40F3-838C-F5AEBF0BB64CQ36568724-50F0E466-71C4-43E0-AC4F-1B5B13C44223Q36979297-27F062D6-F577-48F0-8CF9-1F56D0F35C84Q37340339-368D7333-2C44-44D6-8ECE-DE41E46BAEB4Q37545006-B1526B34-A3D2-4647-A782-1718FF481E35Q37948164-ACBCFA81-183A-48E6-A996-1877B9FF0A1AQ38052178-A5A010AD-EC22-44ED-B09F-3835253DD4FEQ38075061-87C20A26-58E3-4D60-BABF-E0343054977DQ38191565-0A606B21-53F5-412A-9346-92D09DD74D21Q39588933-1025E8BD-7D74-4398-A3FD-62337A71F527Q39614002-F698698D-F38F-4997-B7CE-92A0FD721D20Q40448487-DFED4B1F-07D1-4F7B-83F9-D298D5ECDDB2Q40967062-08438127-B071-4475-8D4E-49A25AFACDBAQ41003245-9A3D6C58-8158-4971-8C55-83419B70EE12Q42033124-1F118F5A-69DF-4A9D-BC06-C68BC1322A5DQ43144114-B8DA9BB7-99E6-47DA-9F19-EBC1DEAF3D2FQ43708647-F1864CA1-9A4F-4CE0-94FF-9FE93B34064CQ43982864-DE5BF02E-935E-432F-9838-DF6BEBF4F1E8Q44106210-211A3160-9745-4798-8C1F-258671A5B510Q46049471-A7F737ED-BC15-4420-B79F-AFD0F258E289Q54347312-DFC12A57-F6B5-44ED-8F68-A27A4F51340D
P2860
The status of antimicrobial resistance of Helicobacter pylori in eastern Europe.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
The status of antimicrobial resistance of Helicobacter pylori in eastern Europe.
@en
The status of antimicrobial resistance of Helicobacter pylori in eastern Europe.
@nl
type
label
The status of antimicrobial resistance of Helicobacter pylori in eastern Europe.
@en
The status of antimicrobial resistance of Helicobacter pylori in eastern Europe.
@nl
prefLabel
The status of antimicrobial resistance of Helicobacter pylori in eastern Europe.
@en
The status of antimicrobial resistance of Helicobacter pylori in eastern Europe.
@nl
P2093
P1476
The status of antimicrobial resistance of Helicobacter pylori in eastern Europe
@en
P2093
A Archimandritis
B Kantarçeken
D Dzierzanowska
G Gosciniak
P304
P356
10.1046/J.1469-0691.2002.00435.X
P577
2002-07-01T00:00:00Z